Cite
APA Citation
Zhang, L., Nesvick, C. L., Day, C. A., Choi, J., Lu, V. M., Peterson, T., Power, E. A., Anderson, J. B., Hamdan, F. H., Decker, P. A., Simons, R., Welby, J. P., Siada, R., Ge, J., Kaptzan, T., Johnsen, S. A., Hinchcliffe, E. H., & Daniels, D. J. (2022). sTAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma. Neuro-oncology, 24(10), 1700–1711. http://access.bl.uk/ark:/81055/vdc_100167547359.0x000021